Regular Review of the Economic Rationale and Holding Purpose of Strategic Shareholdings
First written in FY2017. 8 of 9 entries say "Advanced", first in FY2019. Latest entry: FY2026.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Following a review of the 10 specific investment shares at the Board of Directors meeting held on 14 May 2026, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Company conducted a periodic review of its 10 specific investment shares and reduced its strategic shareholdings by selling 1 holding. It recognized a ¥519 million gain on sales of investment securities, indicating that its review and reduction policy had progressed to actual sales. - FY2026-H1AdvancedAnnual report
「In addition to gains on sales of investment securities arising from the partial reduction of strategic shareholdings, the Company recognized gains on sales of property, plant and equipment from real estate sales, as in the previous fiscal year. As a result, interim net income attributable to owners of the parent was ¥1,071 million, up 113.8% year on year.」
The Company proceeded with a partial reduction of its strategic shareholdings and recognized a ¥519 million gain on sales of investment securities. Its policy of periodic review and reduction has progressed to actual sales. - FY2025AdvancedAnnual report
「Following a review of the 10 specific investment shares at the Board of Directors meeting held on 14 May 2025, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate. One holding scheduled for sale as part of the reduction of strategic shareholdings was excluded from the review.」
The Board of Directors reviewed 10 specific investment shares and determined that all holdings were appropriate, while excluding 1 holding from the review because it was scheduled for sale as part of the reduction of strategic shareholdings. - FY2024AdvancedAnnual report
「Following a review of the 11 specific investment shares at the Board of Directors meeting held on 10 May 2024, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Company conducted an annual review of its 11 specific investment shares at the Board of Directors meeting held on 10 May 2024 and determined that all holdings were appropriate. - FY2023AdvancedAnnual report
「Following a review of the 11 specific investment shares at the Board of Directors meeting held on 12 May 2023, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Company conducted an annual review of its 11 strategic shareholdings at the Board of Directors meeting held on 12 May 2023 and determined that all holdings were appropriate. The review methodology specifies dividend yields, holding costs and the cost of capital, among other factors. - FY2022AdvancedAnnual report
「Following a review of the 11 specific investment shares at the Board of Directors meeting held on 13 May 2022, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Board of Directors conducted an annual review of the 11 specific investment shares, examining their holding purposes and the relationship between their benefits and risks and the cost of capital, and determined that all holdings were appropriate. - FY2020AdvancedAnnual report
「Following a review of the 11 specific investment shares at the Board of Directors meeting held on 22 May 2020, the Board determined that the purpose of holding each share was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Board of Directors reviewed the 11 strategic shareholdings and confirmed the rationale for their holding purposes, benefits and risks for all holdings. The Company had sold 2 holdings since the previous fiscal year. - FY2019AdvancedAnnual report
「Of the 13 specific investment shares, the Board of Directors reviewed 12 holdings at its meeting held on 10 May 2019, excluding 1 holding for which a policy to sell all shares had already been decided. The Board determined that the purpose of holding each of the 12 holdings was appropriate, that the benefits and risks associated with holding them were commensurate with the cost of capital, and that the holdings were appropriate.」
The Board of Directors reviewed 12 of the 13 specific investment shares, excluding the 1 holding for which a sale policy had already been decided, and confirmed the rationale for their holding purposes, benefits and risks. - FY2017First statedAnnual report
「The Company periodically reviews its specific investment shares, including at the time of acquisition, particularly its major holdings, with respect to their medium- to long-term economic rationale and future outlook based on the returns and risks associated with holding them, as well as the objectives and rationale for holding them.」
The Company stated for the first time as a specific policy that it would periodically review its strategic shareholdings, including at the time of acquisition, based on returns and risks, economic rationale, and the future outlook.